Stock 3750 CYTORI CELL RESEARCH INSTITUTE, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Financials Cytori Cell Research Institute, Inc.

Equities

3750

JP3426500009

Real Estate Services

Market Closed - Japan Exchange
Other stock markets
 07:00:00 15/05/2024 BST 		5-day change 1st Jan Change
972 JPY -3.57% Intraday chart for Cytori Cell Research Institute, Inc. +2.64% -14.66%
03-13 Samty Hotel Management K.K. agreed to acquire Hotel Kanazawa Co., Ltd. from Cytori Cell Research Institute, Inc.. CI
2023 Cytori Cell Research Institute,Inc. Reports Earnings Results for the Full Year Ended March 31, 2023 CI

Valuation

Fiscal Period: March 2018 2019 2020 2021 2022 2023
Capitalization 1 3,075 3,014 6,363 12,553 10,349 10,116
Enterprise Value (EV) 1 4,280 4,760 14,129 20,017 18,765 17,499
P/E ratio 6.93 x 5.09 x 19.9 x -14.2 x -133 x -9.55 x
Yield 2.18% 4.45% 1.05% - - -
Capitalization / Revenue 5.89 x 1.57 x 5.39 x 9.04 x 7.75 x 4.72 x
EV / Revenue 8.2 x 2.47 x 12 x 14.4 x 14.1 x 8.16 x
EV / EBITDA 30.6 x 13.9 x 329 x -47.1 x -132 x -37.6 x
EV / FCF -2.62 x -1.62 x 206 x 1,884 x 6.52 x 11.7 x
FCF Yield -38.2% -61.8% 0.49% 0.05% 15.3% 8.58%
Price to Book 1 x 0.84 x 1.67 x 3.54 x 2.79 x 3.81 x
Nbr of stocks (in thousands) 6,714 6,713 6,712 8,711 8,929 8,929
Reference price 2 458.0 449.0 948.0 1,441 1,159 1,133
Announcement Date 20/06/18 26/06/19 25/06/20 24/06/21 23/06/22 23/06/23
1JPY in Million2JPY
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: March 2018 2019 2020 2021 2022 2023
Net sales 1 522 1,924 1,180 1,388 1,335 2,144
EBITDA 1 140 342 43 -425 -142 -465
EBIT 1 131 293 -129 -731 -462 -795
Operating Margin 25.1% 15.23% -10.93% -52.67% -34.61% -37.08%
Earnings before Tax (EBT) 1 450 593 319 -654 -66 -1,165
Net income 1 449 592 319 -831 -77 -1,059
Net margin 86.02% 30.77% 27.03% -59.87% -5.77% -49.39%
EPS 2 66.11 88.19 47.52 -101.5 -8.720 -118.6
Free Cash Flow 1 -1,636 -2,940 68.75 10.62 2,879 1,502
FCF margin -313.51% -152.83% 5.83% 0.77% 215.66% 70.03%
FCF Conversion (EBITDA) - - 159.88% - - -
FCF Conversion (Net income) - - 21.55% - - -
Dividend per Share 2 10.00 20.00 10.00 - - -
Announcement Date 20/06/18 26/06/19 25/06/20 24/06/21 23/06/22 23/06/23
1JPY in Million2JPY
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: March 2020 S1 2021 S1 2022 S1 2022 Q3 2023 Q1 2023 S1 2023 Q3 2024 Q1 2024 S1 2024 Q3
Net sales 1 138 528 668 371 543 1,172 479 472 862 549
EBITDA - - - - - - - - - -
EBIT 1 29 -566 -259 -36 -162 -380 -135 -137 -354 -140
Operating Margin 21.01% -107.2% -38.77% -9.7% -29.83% -32.42% -28.18% -29.03% -41.07% -25.5%
Earnings before Tax (EBT) 1 24 -479 -47 88 -293 -539 -171 -165 -419 -113
Net income 1 24 -119 -34 95 -287 -561 -161 -161 -443 -109
Net margin 17.39% -22.54% -5.09% 25.61% -52.85% -47.87% -33.61% -34.11% -51.39% -19.85%
EPS 2 3.650 -15.57 -3.900 10.87 -32.21 -62.86 -18.09 -18.07 -49.65 -12.25
Dividend per Share - - - - - - - - - -
Announcement Date 01/11/19 06/11/20 10/11/21 10/02/22 10/08/22 11/11/22 10/02/23 10/08/23 10/11/23 09/02/24
1JPY in Million2JPY
Estimates

Balance Sheet Analysis

Fiscal Period: March 2018 2019 2020 2021 2022 2023
Net Debt 1 1,205 1,746 7,766 7,464 8,416 7,383
Net Cash position 1 - - - - - -
Leverage (Debt/EBITDA) 8.607 x 5.105 x 180.6 x -17.56 x -59.27 x -15.88 x
Free Cash Flow 1 -1,637 -2,940 68.8 10.6 2,879 1,502
ROE (net income / shareholders' equity) 15.5% 17.7% 8.56% -21% -2.12% -33.2%
ROA (Net income/ Total Assets) 1.99% 2.85% -0.7% -3.01% -1.87% -3.3%
Assets 1 22,523 20,784 -45,442 27,653 4,124 32,073
Book Value Per Share 2 458.0 536.0 568.0 407.0 416.0 297.0
Cash Flow per Share 2 148.0 228.0 149.0 123.0 95.30 126.0
Capex - - - 15 180 158
Capex / Sales - - - 1.08% 13.48% 7.37%
Announcement Date 20/06/18 26/06/19 25/06/20 24/06/21 23/06/22 23/06/23
1JPY in Million2JPY
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Real Estate Services

1st Jan change Capi.
CYTORI CELL RESEARCH INSTITUTE, INC. Stock Cytori Cell Research Institute, Inc.
-14.66% 57.54M
CBRE GROUP, INC. Stock CBRE Group, Inc.
-4.69% 26.76B
KE HOLDINGS INC. Stock KE Holdings Inc.
+10.06% 21.71B
ZILLOW GROUP, INC. Stock Zillow Group, Inc.
-22.69% 10.51B
CAPITALAND INVESTMENT LIMITED Stock CapitaLand Investment Limited
-17.41% 9.76B
JONES LANG LASALLE INCORPORATED Stock Jones Lang LaSalle Incorporated
+4.17% 9.36B
FIRSTSERVICE CORPORATION Stock FirstService Corporation
-5.43% 6.69B
COLLIERS INTERNATIONAL GROUP INC. Stock Colliers International Group Inc.
-7.77% 5.69B
MAKKAH CONSTRUCTION AND DEVELOPMENT COMPANY Stock Makkah Construction and Development Company
+39.43% 4.63B
CUSHMAN & WAKEFIELD PLC Stock Cushman & Wakefield plc
+0.74% 2.49B
Other Real Estate Services
  1. Stock Market
  2. Equities
  3. 3750 Stock
  4. Financials Cytori Cell Research Institute, Inc.